drug · protein
motixafortide acetate
Marketedupdated 5mo agoby $BLRX BioLineRx Ltd.🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for multiple myeloma and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 8, 2028
~1.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Dec 29, 2041formulationUS 12257285
- Dec 29, 2041formulationUS 12268725
FDA exclusivities (2)
- Sep 8, 2030ODE-442Orphan Drug (7y)3.9y
- Sep 8, 2028NCENew Chemical Entity (5y)1.9y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 55m ago
Found something off?
comments(0)
5-min edit window · permanent after that